What beta blockers (beta-adrenergic blocking agents) can be used for migraine prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beta Blockers for Migraine Prevention

First-Line Beta Blockers with Proven Efficacy

Propranolol (80-240 mg/day) and timolol (20-30 mg/day) are the only beta blockers recommended as first-line agents for migraine prevention, with propranolol having the strongest evidence base. 1, 2

Propranolol

  • Propranolol is the most extensively studied beta blocker for migraine prevention, demonstrating efficacy in 19 of 21 controlled trials. 3
  • The American Academy of Neurology and American Headache Society classify propranolol as Level A evidence (effective and should be offered to patients). 4
  • Dosing range: 80-240 mg per day, initiated at low doses and titrated slowly. 1, 2
  • Propranolol is superior to other agents for patients with pure migraine (without tension-type headache features). 1
  • Clinical benefits may not become apparent for 2-3 months, requiring an adequate trial period. 1, 2

Timolol

  • Timolol is the only other beta blocker with Level A evidence for migraine prevention. 4
  • Dosing range: 20-30 mg per day. 1
  • Good evidence supports its efficacy alongside propranolol. 1

Other Beta Blockers with Supporting Evidence

Metoprolol

  • Metoprolol has demonstrated effectiveness in controlled trials for migraine prophylaxis. 3, 5
  • The American Academy of Neurology classifies metoprolol as Level A evidence. 4

Atenolol and Nadolol

  • Both atenolol and nadolol have been shown effective in double-blind clinical trials. 3, 6, 5
  • These agents represent alternative options when propranolol or timolol are not tolerated. 3

Bisoprolol

  • Bisoprolol has been demonstrated effective in migraine prophylaxis. 5

Critical Contraindication: Beta Blockers with Intrinsic Sympathomimetic Activity (ISA)

Beta blockers with ISA are completely ineffective for migraine prevention and should never be used. 2, 3

  • Ineffective agents include: alprenolol, oxprenolol, pindolol, and acebutolol. 3, 5
  • The only property consistently correlated with anti-migraine efficacy is the absence of ISA. 3, 6
  • Drugs without ISA are effective; partial agonists are not. 3

Common Side Effects and Monitoring

  • Common adverse effects include fatigue, depression, nausea, dizziness, and insomnia, though these are generally well tolerated. 1, 2
  • Monitor for mood changes, particularly depression. 2
  • Monitor for sleep disturbances. 2

Absolute Contraindications

  • Bradycardia 2
  • Heart block 2
  • Hypoglycemic episodes 2
  • Hypersensitivity to the specific beta blocker 2

Treatment Initiation and Duration

  • Start with low doses and increase slowly to minimize side effects. 1, 2
  • An adequate trial requires 2-3 months at therapeutic doses before declaring treatment failure. 1, 2
  • After achieving stability, consider tapering or discontinuing the medication. 1

Clinical Decision Algorithm

For pure migraine: Choose propranolol 80-240 mg/day as first-line. 1

For mixed migraine and tension-type headache: Consider amitriptyline instead, as it demonstrates superior efficacy in this population. 1

If propranolol fails or is not tolerated: Trial timolol 20-30 mg/day or metoprolol. 1, 4

Never use: Beta blockers with ISA (pindolol, acebutolol, alprenolol, oxprenolol). 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Propranolol Dosing for Migraine Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Beta-blockers and migraine].

Pathologie-biologie, 1992

Research

[Beta blockers in migraine prophylaxis].

Brain and nerve = Shinkei kenkyu no shinpo, 2009

Research

Beta-adrenoceptor blockade and migraine.

Cephalalgia : an international journal of headache, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.